Is Hangzhou Tigermed stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Hangzhou Tigermed pays dividends. Last time was Thursday 18th of July 2024 where the investors holding the stock on Friday 7th of June 2024 were paid HKD0.62365 per share. Over the last 5 times between 2021 and 2024, Hangzhou Tigermed has paid HKD2.80436 with an average of HKD0.56 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Hangzhou Tigermed 10 years ago, but if you had invested on Friday 7th of August 2020 when the price was HKD113.30, you would have made a loss of HKD-85.60 per share or -75.55%
Yes, the average daily trading liquidity for Hangzhou Tigermed is HKD1.42 million. You should therefore be able to get in and out of your positions relatively fast.
Hangzhou Tigermed has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.35, the company's ability to pay off the debt is normal. Hangzhou Tigermed has a very good net profit margin of 23.36% and should have very high tolerances against inflation.
We have calculated the inflation risk for Hangzhou Tigermed to be low [0.3 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.